Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC–MS/MS

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 1060, Issue , 2017, Pages 300-307

  Waitt, Catriona ^a,b,c   Diliiy Penchala, Sujan ^a   Olagunju, Adeniyi ^a,d   Amara, Alieu ^a   Else, Laura ^a   Lamorde, Mohammed ^b   Khoo, Saye ^a,c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^d OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

Antiretroviral; Liquid chromatography; Mass spectrometry

Indexed keywords

ACETONITRILE; BLOOD; CHROMATOGRAPHY; DISEASES; FORMIC ACID; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

ANTIRETROVIRALS; CHROMATOGRAPHIC SEPARATIONS; CLINICAL APPLICATION; CONCENTRATION RANGES; DETECTION AND QUANTIFICATIONS; DRIED BLOOD SPOT (DBS); LOW-RESOURCE SETTINGS; TRIPLE-QUADRUPOLE MASS SPECTROMETER;

DATABASE SYSTEMS;

ACETONITRILE; EMTRICITABINE; FORMIC ACID; LAMIVUDINE; TENOFOVIR; WATER; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; BREAST MILK; CONTROLLED STUDY; CORRELATION ANALYSIS; DILUTION; DRIED BLOOD SPOT TESTING; HUMAN; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MEASUREMENT ACCURACY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VALIDATION STUDY; ADULT; AREA UNDER THE CURVE; BLOOD; CHEMISTRY; COHORT ANALYSIS; FEMALE; INFANT; LIQUID CHROMATOGRAPHY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

ADULT; ANTI-HIV AGENTS; AREA UNDER CURVE; CHROMATOGRAPHY, LIQUID; COHORT STUDIES; DRIED BLOOD SPOT TESTING; EMTRICITABINE; FEMALE; HUMANS; INFANT; LAMIVUDINE; LINEAR MODELS; MILK, HUMAN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TENOFOVIR; YOUNG ADULT;

EID: 85021131296     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2017.06.012     Document Type: Article

References (24)

1. WHO, Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. 2013, World Health Organisation, Geneva.
2. WHO, Guidelines on HIV and Infant Feeding 2010. 2010.
3. Fogel, J.M., Mwatha, A., Richardson, P., Brown, E.R., Chipato, T., Alexandre, M., Moodley, D., Elbireer, A., Mirochnick, M., George, K., Mofenson, L.M., Zwerski, S., Coovadia, H.M., Eshleman, S.H., Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants. Pediatr. Infect. Dis. J. 32 (2013), e164–e169.
4. Zeh, C., Weidle, P.J., Nafisa, L., Lwamba, H.M., Okonji, J., Anyango, E., Bondo, P., Masaba, R., Fowler, M.G., Nkengasong, J.N., Thigpen, M.C., Thomas, T., HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis. PLoS Med., 8, 2011, e1000430.
5. Wang, L., Kourtis, A.P., Ellington, S., Legardy-Williams, J., Bulterys, M., Safety of tenofovir during pregnancy for the mother and fetus: a systematic review. Clin. Infect. Dis. 57 (2013), 1773–1781.
6. Olagunju, A., Bolaji, O., Amara, A., Waitt, C., Else, L., Adejuyigbe, E., Siccardi, M., Back, D., Khoo, S., Owen, A., Breast milk pharmacokinetics of efavirenz and Breastfed infants’ exposure in genetically defined subgroups of mother-infant pairs: an observational study. Clin. Infect. Dis. 61:3 (2015), 453–463, 10.1093/cid/civ317.
7. Corbett, A.H., Kayira, D., White, N.R., Davis, N.L., Kourtis, A.P., Chasela, C., Martinson, F., Phiri, G., Musisi, B., Kamwendo, D., Hudgens, M.G., Hosseinipour, M.C., Nelson, J.A., Ellington, S.R., Jamieson, D.J., van der Horst, C., Kashuba, A., B.A.N.S.T. the, Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post partum: results of the BAN Study. Antivir. Ther. 19:6 (2014), 587–595, 10.3851/imp2739.
8. Benaboud, S., Pruvost, A., Coffie, P.A., Ekouevi, D.K., Urien, S., Arrive, E., Blanche, S., Theodoro, F., Avit, D., Dabis, F., Treluyer, J.M., Hirt, D., Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2. Antimicrob. Agents Chemother. 55 (2011), 1315–1317.
9. Mirochnick, M., Taha, T., Kreitchmann, R., Nielsen-Saines, K., Kumwenda, N., Joao, E., Pinto, J., Santos, B., Parsons, T., Kearney, B., Emel, L., Herron, C., Richardson, P., Hudelson, S.E., Eshleman, S.H., George, K., Fowler, M.G., Sato, P., Mofenson, L., Team, H.P., Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life. J. Acquir. Immune Defic. Syndr. 65 (2014), 33–41.
10. Palombi, L., Pirillo, M.F., Marchei, E., Jere, H., Sagno, J.B., Luhanga, R., Floridia, M., Andreotti, M., Galluzzo, C.M., Pichini, S., Mwenda, R., Mancinelli, S., Marazzi, M.C., Vella, S., Liotta, G., Giuliano, M., Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the Option B-Plus approach in Malawi. J. Antimicrob. Chemother. 71 (2016), 1027–1030.
11. Waitt, C.J., Garner, P., Bonnett, L.J., Khoo, S.H., Else, L.J., Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studies. J. Antimicrob. Chemother 70:7 (2015), 1928–1941, 10.1093/jac/dkv080.
12. Olagunju, A., Bolaji, O.O., Amara, A., Waitt, C., Else, L., Soyinka, J., Adeagbo, B., Adejuyigbe, E., Siccardi, M., Back, D., Owen, A., Khoo, S., Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS. J. Antimicrob. Chemother. 70 (2015), 555–561.
13. Olagunju, A., Amara, A., Waitt, C., Else, L., Penchala, S.D., Bolaji, O., Soyinka, J., Siccardi, M., Back, D., Owen, A., Khoo, S., Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast-milk spots. J. Antimicrob. Chemother. 70:10 (2015), 2816–2822, 10.1093/jac/dkv174.
14. Meesters, R.J., Wolfe, R.R., Deutz, N.E., Application of liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the analysis of stable isotope enrichments of phenylalanine and tyrosine. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 877 (2009), 43–49.
15. Matuszewski, B.K., Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 830 (2006), 293–300.
16. FDA, Guidance for Industry: Bioanalytical Method Validation. 2001.
17. Koster, R.A., Alffenaar, J.W., Botma, R., Greijdanus, B., Touw, D.J., Uges, D.R., Kosterink, J.G., What is the right blood hematocrit preparation procedure for standards and quality control samples for dried blood spot analysis?. Bioanalysis 7 (2015), 345–351.
18. Olagunju, A., Bolaji, O., Amara, A., Waitt, C., Else, L., Adejuyigbe, E., Siccardi, M., Back, D., Khoo, S., Owen, A., Breast milk pharmacokinetics of efavirenz and breastfed infants’ exposure in genetically-defined subgroups of mother-infant pairs: an observational study. Clin. Infect. Dis. 61:3 (2015), 453–463, 10.1093/cid/civ317.
19. Jackson, A., Moyle, G., Watson, V., Tjia, J., Ammara, A., Back, D., Mohabeer, M., Gazzard, B., Boffito, M., Tenofovir, emtricitabine intracellular and plasma, and efavirenz plasma concentration decay following drug intake cessation: implications for HIV treatment and prevention. J. Acquir. Immune Defic. Syndr. 62 (2013), 275–281.
20. Castillo-Mancilla, J.R., Zheng, J.H., Rower, J.E., Meditz, A., Gardner, E.M., Predhomme, J., Fernandez, C., Langness, J., Kiser, J.J., Bushman, L.R., Anderson, P.L., Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure. AIDS Res. Hum. Retroviruses 29 (2013), 384–390.
21. Zheng, J.H., Guida, L.A., Rower, C., Castillo-Mancilla, J., Meditz, A., Klein, B., Kerr, B.J., Langness, J., Bushman, L., Kiser, J., Anderson, P.L., Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS. J. Pharm. Biomed. Anal. 88 (2014), 144–151.
22. Denniff, P., Spooner, N., Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis. Anal. Chem. 86 (2014), 8489–8495.
23. Shapiro, R.L., Holland, D.T., Capparelli, E., Lockman, S., Thior, I., Wester, C., Stevens, L., Peter, T., Essex, M., Connor, J.D., Mirochnick, M., Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment. J. Infect. Dis. 192 (2005), 720–727.
24. Fogel, J., Li, Q., Taha, T.E., Hoover, D.R., Kumwenda, N.I., Mofenson, L.M., Kumwenda, J.J., Fowler, M.G., Thigpen, M.C., Eshleman, S.H., Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants. Clin. Infect. Dis. 52 (2011), 1069–1076.